Does APIXABAN Cause Upper respiratory tract infection? 115 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 115 reports of Upper respiratory tract infection have been filed in association with APIXABAN (ELIQUIS). This represents 0.1% of all adverse event reports for APIXABAN.
115
Reports of Upper respiratory tract infection with APIXABAN
0.1%
of all APIXABAN reports
2
Deaths
61
Hospitalizations
How Dangerous Is Upper respiratory tract infection From APIXABAN?
Of the 115 reports, 2 (1.7%) resulted in death, 61 (53.0%) required hospitalization, and 36 (31.3%) were considered life-threatening.
Is Upper respiratory tract infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 115 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Upper respiratory tract infection?
ADALIMUMAB (3,306)
ETANERCEPT (2,948)
TOFACITINIB (1,805)
RITUXIMAB (1,713)
ABATACEPT (1,623)
METHOTREXATE (1,576)
TOCILIZUMAB (1,455)
APREMILAST (1,437)
PREDNISONE (1,354)
SECUKINUMAB (1,339)
Which APIXABAN Alternatives Have Lower Upper respiratory tract infection Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ